Table 3. Clinical and procedural outcomes.
Clinical and procedural outcomes | ||
Residual stenosis ≤30% | 231 (92.4) | |
Degree of stenosis | Baseline * | 81.44±7.9 |
Post procedure * | 21.82±9.4 (p=0.021) | |
Ankle-brachial index | Baseline | 0.46±0.23 |
Post procedure | 0.82±0.21 (p<0.001) | |
Follow-up | 0.8±0.22 (p<0.001) | |
Rutherford-Becker class | Baseline | 3.2±0.68 |
Follow-up | 2.04±0.64 (p<0.001) | |
cdTLR | 34 (13.6) | |
Endovascular reintervention | 21 (8.4) | |
Open, surgical treatment | 13 (5.2) | |
Time to cdTLR (in months) | 27.41±13.77 | |
Major amputation | 0 | |
Minor amputation | 2 (0.8) | |
Freedom from major adverse events | 249 (99.6) | |
Values are n (%) or mean±SD. * by visual estimation. cdTLR: clinically driven target lesion revascularisation |